Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Re Contract

9 Jul 2008 07:00

RNS Number : 6296Y
First Derivatives PLC
09 July 2008
 

9 July 2008

First Derivatives plc 

(AIM:FDP.L, IEX:GYQ.I)

Software License Sale

The Board of First Derivatives plc ("First Derivatives" or the "Company") is pleased to announce that it has signed its first global contract for its qAlgo algorithmic trading product The sale is to a major financial institution operating in LondonNew York and Asia. The transaction includes both a substantial initial payment for implementation and an annually renewable license fee. 

The Company has made a major investment in developing a suite of trading, risk, CEP and market data focussed software. qAlgo, which represents just one product in the suite, was launched last year and has been well received.  This sale validates First Derivatives' strategy of developing its own branded products for the financial services market.

Commenting on the contract win, Michael ONeill, Chief Operating Officer Company said: "First Derivatives is at the forefront of the development and implementation of algorithmic trading systems. We have built an excellent reputation through our consulting services, customised application development and successful implementations of third party software but now we can supplement this business with our own suite of software.  The Board is very pleased to have secured its first global contract win of qAlgo.  We anticipate announcing further progress in the coming weeks as the Company is continuing to experience an encouraging level of enquiries in all areas of our business."

Contact:

First Derivatives plc

Brian Conlon

Tel: +44 (0)28 3025 2242

Charles Stanley Securities

Nominated Adviser

Russell Cook/Carl Holmes

Tel: +44 (0)20 7149 6000

Goodbody Corporate Finance 

IEX Adviser

Diane Hodgson/Linda Hickey

Tel: +353 1 667 0420

Stakeholder Communications 

Carl Whyte 

Lisa Nugent

Tel: +44 (0)28 9033 9949

Tel: +44 (0) 20 7903 5148

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUUUPUMUPRGMR
Date   Source Headline
17th Aug 20074:59 pmRNSDisclosure of Information
3rd Aug 200712:01 pmRNSExercise of options
27th Jul 20073:11 pmRNSTotal Voting Rights
6th Jul 200712:41 pmRNSExercise of Options
8th Jun 20077:00 amRNSIEX Notice
7th Jun 20072:08 pmRNSResult of AGM
6th Jun 20075:27 pmRNSIEX Schedule One Update
21st May 200710:32 amRNSDirector/PDMR Shareholding
18th May 200710:21 amRNSFinal Results - REPLACEMENT
10th May 200710:48 amRNSIEX Schedule One
10th May 20077:01 amRNSFinal Results
3rd Apr 20079:29 amRNSTotal Voting Rights
6th Mar 20071:25 pmRNSExercise of Options
28th Feb 20073:14 pmRNSTotal Voting Rights
27th Feb 20072:07 pmRNSIssue of Equity
8th Feb 20077:00 amRNSTrading Statement
31st Jan 20071:55 pmRNSTotal Voting Rights
30th Jan 20077:01 amRNSExercise of Options
12th Jan 20075:24 pmRNSDirector/PDMR Shareholding
11th Jan 20074:59 pmRNSDirector/PDMR Shareholding
20th Dec 20064:29 pmRNSTotal Voting Rights
20th Dec 20064:20 pmRNSIssue of Equity
19th Oct 20063:41 pmRNSDirector/PDMR Shareholding
5th Oct 20068:52 amRNSExercise of Options
26th Sep 20067:01 amRNSInterim Results
1st Jun 200612:05 pmRNSResult of AGM
22nd May 20063:09 pmRNSDirector/PDMR Shareholding
9th May 20065:53 pmRNSDividend Update Statement
9th May 20067:01 amRNSFinal Results
24th Apr 20062:50 pmRNSNotice of Results
17th Mar 20067:02 amRNSTrading Statement
10th Mar 20062:49 pmRNSExercise of Options
10th Mar 20062:38 pmRNSDirector/PDMR Shareholding
24th Nov 20057:01 amRNSDirectorate Change
7th Oct 20053:24 pmRNSDirector/PDMR Shareholding
22nd Sep 20057:00 amRNSInterim Results
28th Jun 20055:26 pmRNSResult of AGM
27th May 20052:37 pmRNSDividend Declaration
25th May 20057:01 amRNSFinal Results
3rd May 20057:00 amRNSTrading update
9th Feb 20052:32 pmRNSNew Contract Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.